Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 51–100 of 77097
René Herzog Deputy Director of Operations The directors are to serve until their successors are duly elected and qualified or their earlier death, resignation or removal.
Freddy Arciniegas Mejía Director; Chief Financial Officer
Benoît Lebrun Director; Chief Executive Officer
Effective upon the closing at 12:00 p.m. Eastern Time on October 6, 2026, Brito resigned as Chief Executive Officer and as a member of the Company’s Board of Directors. His resignation was voluntary and was not the result of any disagreement with the Company concerning its operations, policies or practices.
Pursuant to the October 6, 2026 board resolutions, the number of directors was fixed at three, and the following elections, designations and appointments became effective at the same Effective Time, subject to closing and the applicable written acceptances: Name Position(s) Maria Salinas Director; Chair of the Board; Acting Secretary
the Board of Directors of the Company (the “Board”) appointed Morris Berger as Chief Executive Officer of the Company, effective October 1, 2026. Mr. Berger commenced service as Chief Executive Officer on October 1, 2026.
On October 8, 2026, the board of directors of Goldenwell Biotech, Inc. (the “Company”) appointed Ming Zhou as a director.
On October 5, 2026, The Marzetti Company (the “Company”) announced that Tanya Berman, President of Retail Division of T. Marzetti Company, a subsidiary of the Company, is no longer serving in this role effective October 6, 2026.
On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the “Company” ), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier of the selection and appointment of her successor or by June 30, 2027.
On October 8, 2026, Erika Fisher, the Chief Legal Officer and Corporate Secretary of HubSpot, Inc. (the "Company"), notified the Company of her decision to resign from the Company, effective November 6, 2026, to pursue another professional opportunity.
On October 8, 2026, the Board of Directors (the “Board”) of Enerpac Tool Group Corp. (the “Company”) adopted resolutions expanding the size of the Board from eight to nine and elected Charles T. Lauber as a director to fill the vacancy created by the expansion in the size of the Board.
Natalie Hirsch was appointed to serve as Chief Financial Officer and Chief Operating Officer,
David Hackett was appointed to the Company’s Board of Directors effective on such date. In connection with his appointment, the Company and Mr. Hackett entered into an agreement pursuant to which the Company will pay Mr. Hackett a cash fee of $100,000 for his first year of Board service and $75,000 for each year thereafter,
Humphrey Polanen resigned from the Company’s Board of Directors effective on such date. Mr. Polanen’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Steven Passey, the Company’s former Chief Financial Officer, was appointed to serve as the Company’s Vice President – Finance of the Company’s golf division.
Also on October 8, 2026, the Board appointed Dr. Guttentag to serve as the Board Observer, effective immediately.
Effective as of immediately following the conclusion of the 2026 Annual Meeting, the Board will increase its size from eight directors to ten directors, nine of whom will be independent, and Dr. Guttentag and Ms. Lawrence will be appointed to serve as directors on the Board, each with a term expiring at the 2027 Annual Meeting and until his or her successor is elected and qualified or until his or her earlier resignation, death or removal.
Effective as of immediately following the conclusion of the 2026 Annual Meeting, the Board will increase its size from eight directors to ten directors, nine of whom will be independent, and Dr. Guttentag and Ms. Lawrence will be appointed to serve as directors on the Board, each with a term expiring at the 2027 Annual Meeting and until his or her successor is elected and qualified or until his or her earlier resignation, death or removal.
In connection with the foregoing, on October 8, 2026, Ms. Lawrence tendered her resignation from the Board and from the Compensation Committee of the Board, effective immediately prior to the Appointment Date and Time. Following the effective time of her resignation, Ms. Lawrence will serve as a non-voting observer to the Board until she is re-appointed to the Board immediately following the conclusion of the 2026 Annual Meeting. Ms. Lawrence’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On October 8, 2026, the Board (i) appointed Mr. Haggart, with effect as from the Appointment Date and Time, to serve as a director on the Board with an initial term expiring at the 2026 Annual Meeting, to fill a vacancy created by Ms. Allison Lawrence’s resignation (discussed below)
effective as of October 8, 2026, Dirk Thye, M.D., resigned as Chief Executive Officer and Chief Medical Officer, as well as a director, of Quince Therapeutics, Inc.
Brendan Hannah resigned as Chief Operating Officer, Chief Business Officer and Chief Compliance Officer of the Company.
Effective October 8, 2026 (the “ Effective Date ”), the Board of Directors (the “ Board ”) of the Company appointed Brigette Roberts, M.D., as Chief Executive Officer of the Company.
elected Michael J. Frank as President and Chief Executive Officer, and as a member of the Board, effective October 7, 2026
Mr. Frank succeeds Dr. Ashish K. Khandpur, who will continue to provide advisory consulting support through 2026.
On October 7, 2026, the Board of Directors (the “Board”) of the Company elected Michael J. Frank as President and Chief Executive Officer, and as a member of the Board, effective October 7, 2026 (the “Effective Date).
On October 9, 2026, Victoria’s Secret & Co. (the “Company”) announced that Melinda McAfee, Chief Legal and Compliance Officer, will be leaving the Company, effective March 31, 2027.
On October 08, 2026, Brogan Ptacin, Executive Vice President and Head of Commercial Banking, and a named executive officer of the Company, provided notice of his decision to retire from his position effective December 31, 2026. Following his retirement, Mr. Ptacin will be employed by the Bank in a non-executive, part-time, advisory capacity for a period of time to be determined.
On October 08, 2026, Mark Fucinato, Executive Vice President and Chief Credit Officer, provided notice of his decision to retire from his position effective December 31, 2026.
On October 08, 2026, the Company and the Bank appointed Scott Hawthorne, age 46, to succeed Mr. Fucinato as Chief Credit Officer, to be effective January 1, 2027.
On October 08, 2026, the Bank appointed Sean H. McGuire, age 58, to the newly created positon of Chief Commercial Banking Officer, to be effective January 1, 2027.
In connection with entering into the Purchase Agreement, the Company entered into an offer letter (the “Offer Letter”) with Jonathan C. Stein, pursuant to which Mr. Stein will continue to serve as Chief Executive Officer of the Company and be appointed to the initial Board.
The description of the expected resignations of Kristi H. McCarthy, Kristen M. Ghattas, Barbara F. Harrison and Gerbert Schoonman as directors of GP LLC at Closing included under “Amendments to Existing Governing Documents” in Item 1.01 is hereby incorporated by reference.
The description of the expected resignations of Kristi H. McCarthy, Kristen M. Ghattas, Barbara F. Harrison and Gerbert Schoonman as directors of GP LLC at Closing included under “Amendments to Existing Governing Documents” in Item 1.01 is hereby incorporated by reference.
The description of the expected resignations of Kristi H. McCarthy, Kristen M. Ghattas, Barbara F. Harrison and Gerbert Schoonman as directors of GP LLC at Closing included under “Amendments to Existing Governing Documents” in Item 1.01 is hereby incorporated by reference.
The description of the expected resignations of Kristi H. McCarthy, Kristen M. Ghattas, Barbara F. Harrison and Gerbert Schoonman as directors of GP LLC at Closing included under “Amendments to Existing Governing Documents” in Item 1.01 is hereby incorporated by reference.
As previously disclosed in the Prior 8-K, Directors Ahmet C. Dorduncu and Kathryn D. Sullivan notified the Board of their intention to retire from Board service effective December 31, 2026.
As previously disclosed in the Prior 8-K, Directors Ahmet C. Dorduncu and Kathryn D. Sullivan notified the Board of their intention to retire from Board service effective December 31, 2026.
On October 5, 2026, John Jubilee notified I-ON Digital Corp. (the “Company”) of his intention to resign as a Director of the Company, effective immediately. Mr. Jubilee’s resignation is not the result of any disagreement between Mr. Jubilee and the Company on any matter relating to the Company’s operations, policies or practices.
On October 2, 2026, Barak Eilam provided Payoneer Global Inc. (the “Company”) with notice of his decision to resign as a director of the Board of Directors (the “Board”) of the Company. Mr. Eilam’s resignation became effective October 5, 2026 (the “Effective Date”).
On October 5, 2026, OG&E’s Board of Directors named John Laws as Chief Operating Officer (“COO”) of OG&E, effective January 4, 2027.
On October 8, 2026, the Board of Directors (the “Board”) of Super Micro Computer, Inc. (the “Company”) appointed Shesha Krishnapura to serve as a member of the Board, effective October 9, 2026. Mr. Krishnapura will serve as an independent director.
On October 7, 2026, Judy Lin, a member of the Board, notified the Company of her decision to retire from the Board. Her service on the Board will conclude on October 9, 2026.
On October 4, 2026, Mr. Aviram informed the Company that he has decided not to join the Company and, accordingly, will not assume the role of Chief Financial Officer.
On October 2, 2026, The Children’s Place, Inc. (the “Company”) appointed Elizabeth A. LaPuma as a member of the Company’s board of directors (the “Board”) and its Audit Commitee.
On October 2, 2026, Cesare Frepoli notified Terra Innovatum Global N.V. (the “Company”) of his intention to resign from the board of directors of the Company (the “Board”), effective as of such date.
On October 8, 2026, MFA Financial, Inc. (“MFA” or the “Company”) announced that Craig L. Knutson, age 67, will be retiring as Chief Executive Officer of the Company effective June 30, 2027, after having served as MFA’s CEO or Co-CEO since July 2017.
On October 8, 2026, MFA announced the appointment of Bryan Wulfsohn, age 43, as CEO of the Company, effective July 1, 2027, following the retirement of Mr. Knutson.
In addition, on October 8, 2026, MFA announced that Mr. Wulfsohn will become a member of its Board of Directors, effective January 1, 2027.
On October 3, 2026, Mr. Thomas Kim, Executive Vice President, Chief Legal Officer & Secretary of Gartner, Inc. (the “Company” or “Gartner”), notified the Company that he will be stepping down from his role effective October 16, 2026 to pursue a new senior executive opportunity.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.